|Study Type:||Phase I|
|Stage:||Follow up complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase I clinical trial to evaluate the immunogenicity of AIDSVAX B/E bivalent gp120 vaccine and MVA/HIV62B in healthy, HIV-1 uninfected adult participants who previously received MVA/HIV62B in DNA/MVA or MVA/MVA regimens in HVTN 205
HVTN 114 is a Phase I clinical trial to evaluate the safety and immunogenicity of a MVA62B and AIDSVAX B/E boost given to participants who received MVA62B in HVTN 205.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.